Home - Products - Metabolic Enzyme/Protease - PPAR - β-Glycerol phosphate disodium salt pentahydrate

β-Glycerol phosphate disodium salt pentahydrate

CAS No. 13408-09-8

β-Glycerol phosphate disodium salt pentahydrate( BETA-GLYCEROL PHOSPHATE DISODIUM SALT | β-Glycerophosphate disodium salt pentahydrate )

Catalog No. M20533 CAS No. 13408-09-8

β-Glycerol phosphate disodium salt pentahydrate is a protein phosphatase inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 49 In Stock
25MG 77 In Stock
50MG 111 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    β-Glycerol phosphate disodium salt pentahydrate
  • Note
    Research use only, not for human use.
  • Brief Description
    β-Glycerol phosphate disodium salt pentahydrate is a protein phosphatase inhibitor.
  • Description
    β-Glycerol phosphate disodium salt pentahydrate is a protein phosphatase inhibitor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    BETA-GLYCEROL PHOSPHATE DISODIUM SALT | β-Glycerophosphate disodium salt pentahydrate
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    PPAR
  • Recptor
    Phosphatase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    13408-09-8
  • Formula Weight
    306.11
  • Molecular Formula
    C3H7Na2O6P
  • Purity
    >98% (HPLC)
  • Solubility
    H2O:50 mg/mL (163.34 mM)
  • SMILES
    O.O.O.O.O.[Na+].[Na+].OCC(CO)OP([O-])([O-])=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Belfield A Goldberg D M . Inhibition of the Nucleotidase Effect of Alkaline Phosphatase by β-Glycerophosphate[J]. Nature 1968 219(5149):73-75.
molnova catalog
related products
  • MSDC-0602K

    MSDC-0602K (Azemiglitazone potassium) (Azemiglitazone potassium) is a PPARγ-sparing thiazolidinedione (Ps-TZD) compound that binds to PPARγ with an IC50 of 18.25 μM.

  • KD-3010

    KD-3010 (Kalypsys) is an orally active potent and selective PPARδ agonist for the study of liver injury.

  • Mifobate

    Mifobate is a potent and specific antagonist of PPARγ. Mifobate shows antiobesity, antidiabetic and antiatherosclerotic effects.